HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

W Matthijs Blankesteijn Selected Research

Peptide Fragments

1/2019The Beneficial Effects of UM206 on Wound Healing After Myocardial Infarction in Mice Are Lost in Follow-Up Experiments.
10/2011Blocking of frizzled signaling with a homologous peptide fragment of wnt3a/wnt5a reduces infarct expansion and prevents the development of heart failure after myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


W Matthijs Blankesteijn Research Topics

Disease

12Infarction (Infarctions)
06/2019 - 02/2008
10Myocardial Infarction
01/2018 - 07/2005
8Heart Failure
01/2020 - 09/2004
4Heart Rupture
11/2019 - 09/2004
4Fibrosis (Cirrhosis)
07/2017 - 12/2008
3Hypertension (High Blood Pressure)
01/2020 - 01/2015
2Cardiomyopathies (Cardiomyopathy)
01/2018 - 11/2011
2Rupture
01/2009 - 06/2008
2Cardiomegaly (Heart Hypertrophy)
04/2008 - 03/2007
1Vascular Calcification
12/2020
1Cognitive Dysfunction
10/2018
1Inflammation (Inflammations)
01/2018
1ST Elevation Myocardial Infarction
07/2017
1Left Ventricular Dysfunction
01/2015
1Disease Progression
07/2014
1Osteosarcoma (Osteogenic Sarcoma)
04/2011
1Neurodegenerative Diseases (Neurodegenerative Disease)
04/2011
1Neoplasms (Cancer)
04/2010
1Cicatrix (Scar)
01/2010
1Hypertrophy
03/2007
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
07/2006
1Vascular System Injuries
02/2002
1Vascular Remodeling
02/2002

Drug/Important Bio-Agent (IBA)

6CollagenIBA
06/2019 - 02/2008
4Angiotensin IIIBA
01/2020 - 09/2004
4beta CateninIBA
04/2010 - 02/2002
2Peptide FragmentsIBA
01/2019 - 10/2011
2Galectin 3 (LGALS3)IBA
01/2018 - 07/2017
2Biomarkers (Surrogate Marker)IBA
01/2016 - 07/2014
2AldosteroneIBA
11/2011 - 02/2009
2EnzymesIBA
11/2011 - 02/2008
2Proteins (Proteins, Gene)FDA Link
06/2008 - 07/2005
1calcium phosphateIBA
12/2020
1UrocortinsIBA
01/2020
1Adhesives (Glues)IBA
06/2019
1Peptides (Polypeptides)IBA
04/2018
1ChemokinesIBA
01/2016
1CD40 Ligand (CD40L)IBA
01/2016
1CXCR3 ReceptorsIBA
01/2016
1LigandsIBA
01/2015
1InterferonsIBA
01/2015
1Growth Hormone (Somatotropin)IBA
01/2015
1Methionine Sulfoxide ReductasesIBA
11/2011
1Adrenergic Agents (Adrenergic Drugs)IBA
11/2011
1Isoproterenol (Isoprenaline)FDA LinkGeneric
11/2011
1CatecholaminesIBA
11/2011
1Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
11/2011
1NADPH Oxidases (NAD(P)H oxidase)IBA
11/2011
1Calcium-Calmodulin-Dependent Protein KinasesIBA
11/2011
1Toxic ActionsIBA
11/2011
1Wnt ProteinsIBA
10/2011
1Frizzled ReceptorsIBA
10/2011
1CateninsIBA
04/2011
1ReninIBA
02/2009
1AngiotensinsIBA
02/2009
1Matrix Metalloproteinases (MMPs)IBA
01/2009
1Matrix Metalloproteinase 8 (Neutrophil Collagenase)IBA
01/2009
1Losartan (Cozaar)FDA LinkGeneric
12/2008
1Captopril (Capoten)FDA LinkGeneric
12/2008
1alpha Catenin (alpha E-Catenin)IBA
06/2008
1Glycogen Synthase Kinase 3IBA
04/2008
1Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)IBA
04/2008
1AntithrombinsIBA
02/2008
1Dalteparin (Dalteparin Sodium)FDA Link
02/2008
1TransglutaminasesIBA
02/2008
1Factor XIII (Coagulation Factor XIII)IBA
02/2008
1Transcription Factors (Transcription Factor)IBA
03/2007
1Glycogen Synthase (Synthase I)IBA
03/2007
1emerinIBA
07/2006
1ProteomeIBA
07/2005
1TCF Transcription FactorsIBA
02/2002

Therapy/Procedure

4Therapeutics
01/2017 - 02/2008
2Sutureless Surgical Procedures
11/2019 - 11/2019
1Ligation
02/2009